NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 41 filers reported holding NEUROPACE INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 5,621,111 | $54,693,410 | 77.70% |
| Soleus Capital Management, L.P. | 2,466,205 | $23,996,175 | 2.21% |
| Kent Lake Capital LLC | 574,417 | $5,589,077 | 2.15% |
| Nantahala Capital Management | 1,219,915 | $11,869,773 | 1.01% |
| Orbimed Advisors | 4,012,281 | $39,039,494 | 0.83% |
| EAM Investors, LLC | 141,616 | $1,377,924 | 0.27% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 60,048 | $584,267 | 0.01% |
| Financial Advocates Investment Management | 10,000 | $97,300 | 0.01% |
| MORGAN STANLEY | 2,399,716 | $23,349,237 | 0.00% |
| FMR LLC | 706,245 | $6,871,765 | 0.00% |